How Is Artrya Poised to Revolutionize U.S. Cardiac Care with FDA Clearance and $80M Raise?

• FDA clearance obtained for Salix Coronary Plaque module with $950 scan reimbursement
• First U.S. commercial revenues recorded from Tanner Health integration
• $80 million capital raise completed to support U.S. market growth
• SAPPHIRE clinical study partners Piedmont Healthcare and Huntsville Hospital Heart Centre confirmed